 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
10-3-2023
Insider Buy |
Baan Bastiaan Jeroen Van Der
President and CEO |
$2.80
CAGR »
|
$28,000.00
10,000 shares |
10-3-2023
Insider Buy |
Rene Bernards
Director |
$2.41
CAGR »
|
$24,115.94
10,000 shares |
12-30-2022
Insider Buy |
Baan Bastiaan Jeroen Van Der
Director |
$0.49
CAGR »
|
$4,900.00
10,000 shares |
12-15-2022
Insider Buy |
Rene Bernards
Director |
$0.51
CAGR »
|
$7,650.00
15,000 shares |
12-12-2022
Insider Buy |
Rene Bernards
Director |
$0.61
CAGR »
|
$6,100.00
10,000 shares |
12-9-2022
Insider Buy |
Eric Forman
Vice President and COO |
$0.61
CAGR »
|
$9,836.06
16,112 shares |
11-21-2022
Insider Buy |
Regina Brown
Director |
$0.58
CAGR »
|
$2,876.00
5,000 shares |
11-18-2022
Insider Buy |
Eric Forman
Vice President and COO |
$0.56
CAGR »
|
$11,744.07
21,059 shares |
11-14-2022
Insider Buy |
Rene Bernards
Director |
$0.53
CAGR »
|
$27,825.00
52,500 shares |
11-30-2020
Insider Buy |
Hung Tak Ho
>10% Owner |
$4.75
CAGR »
|
$199,998.75
42,105 shares |
11-30-2020
Insider Buy |
Gil Schwartzberg
>10% Owner |
$4.75
CAGR »
|
$500,004.00
105,264 shares |
11-30-2020
Insider Buy |
Robert Greenberg
>10% Owner |
$4.75
CAGR »
|
$250,002.00
52,632 shares |
11-30-2020
Insider Buy |
Stephen J. Forman
Director |
$4.75
CAGR »
|
$100,001.75
21,053 shares |
11-30-2020
Insider Buy |
Philip F. Palmedo
Director |
$4.75
CAGR »
|
$100,001.75
21,053 shares |
11-30-2020
Insider Buy |
John S. Kovach
President and CEO |
$4.75
CAGR »
|
$100,225.00
21,100 shares |
1-11-2017
Insider Buy |
Gil Schwartzberg
>10% Owner |
$0.06
CAGR »
|
$59,327.80
1,005,556 shares |
Also See: Institutional Holders of LIXT
Also See: SEC filings
Below we present the annualized performance delivered by Lixte Biotechnology Holdings stock since 10-3-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Lixte Biotechnology Holdings insider buying occurred is the ultimate
test of whether insiders were right about LIXT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/04/2023 |
|
| End date: |
04/30/2024 |
|
| Start price/share: |
$2.48 |
|
| End price/share: |
$2.76 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
11.29% |
|
| Annualized Gain: |
19.72% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,129.00 |
|
| Years: |
0.57 |
|
Lixte Biotechnology Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Lixte Biotechnology Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding LIXT
|
|
Free LIXT Email Alerts:
